Beata Szeszko1, Karolina Osowiecka1, Monika Rucińska2, Ewa Wasilewska-Teśluk2, Krzysztof Gliński1, Lucyna Kępka1. 1. Independent Public Health Care Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Centre, Al. Wojska Polskiego 37, 10-228 Olsztyn, Poland. 2. Independent Public Health Care Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Centre, Al. Wojska Polskiego 37, 10-228 Olsztyn, Poland ; Department of Oncology, University of Warmia & Mazury, Olsztyn, Poland.
Abstract
AIM: We compared the incidence of RTOG/EORTC grade III and higher acute mucositis in patients with head and neck cancer who continued to smoke during radiotherapy with those who quit smoking. BACKGROUND: There are conflicting data on the relationship between smoking during radiotherapy and the severity of acute mucosal reaction. More studies dealing with this issue are needed. MATERIALS AND METHODS: Among 136 patients receiving curative radio(chemo)therapy, 37 (27%) declared that they had not quit smoking during radiotherapy. The intensity of mucositis was scored daily by a nurse and weekly by a physician using the RTOG/EORTC scale. The main end-point of the study was the highest observed RTOG/EORTC grade of mucositis. RESULTS: Patients who smoked during radiotherapy (smokers) were younger than their counterparts who quit smoking (non-smokers), p = 0.06. There were no other differences in the baseline characteristics between smokers and non-smokers. Grade III/IV acute mucositis was observed in 43.5% of all patients. The percentage of patients with grade III/IV acute mucositis was similar in smokers and non-smokers (46% vs. 42%, p = 0.71). Nine patients (smokers [13.5%]; non-smokers [4%], p = 0.05) required prolonged hospitalization to heal mucositis. CONCLUSIONS: In the whole group, smoking during radiotherapy was not related to acute mucosal toxicity evaluated as the rate of the highest observed grade of mucositis.
AIM: We compared the incidence of RTOG/EORTC grade III and higher acute mucositis in patients with head and neck cancer who continued to smoke during radiotherapy with those who quit smoking. BACKGROUND: There are conflicting data on the relationship between smoking during radiotherapy and the severity of acute mucosal reaction. More studies dealing with this issue are needed. MATERIALS AND METHODS: Among 136 patients receiving curative radio(chemo)therapy, 37 (27%) declared that they had not quit smoking during radiotherapy. The intensity of mucositis was scored daily by a nurse and weekly by a physician using the RTOG/EORTC scale. The main end-point of the study was the highest observed RTOG/EORTC grade of mucositis. RESULTS:Patients who smoked during radiotherapy (smokers) were younger than their counterparts who quit smoking (non-smokers), p = 0.06. There were no other differences in the baseline characteristics between smokers and non-smokers. Grade III/IV acute mucositis was observed in 43.5% of all patients. The percentage of patients with grade III/IV acute mucositis was similar in smokers and non-smokers (46% vs. 42%, p = 0.71). Nine patients (smokers [13.5%]; non-smokers [4%], p = 0.05) required prolonged hospitalization to heal mucositis. CONCLUSIONS: In the whole group, smoking during radiotherapy was not related to acute mucosal toxicity evaluated as the rate of the highest observed grade of mucositis.
Entities:
Keywords:
Acute mucositis; Head and neck cancer; Radiochemotherapy; Radiotherapy; Smoking status
Authors: Deborah B McGuire; Maria Elvira P Correa; Judith Johnson; Patricia Wienandts Journal: Support Care Cancer Date: 2006-04-25 Impact factor: 3.603
Authors: Allen M Chen; Leon M Chen; Andrew Vaughan; Radhika Sreeraman; D Gregory Farwell; Quang Luu; Derick H Lau; Kerri Stuart; James A Purdy; Srinivasan Vijayakumar Journal: Int J Radiat Oncol Biol Phys Date: 2010-04-14 Impact factor: 7.038
Authors: Luke J Peppone; Karen M Mustian; Gary R Morrow; Ann M Dozier; Deborah J Ossip; Michelle C Janelsins; Lisa K Sprod; Scott McIntosh Journal: Oncologist Date: 2011-12-01
Authors: George P Browman; E Ann Mohide; Andrew Willan; Ian Hodson; Gene Wong; Laval Grimard; Robert G MacKenzie; Samy El-Sayed; Edward Dunn; Sylvia Farrell Journal: Head Neck Date: 2002-12 Impact factor: 3.147
Authors: Andy Trotti; Lisa A Bellm; Joel B Epstein; Diana Frame; Henry J Fuchs; Clement K Gwede; Eugene Komaroff; Luba Nalysnyk; Marya D Zilberberg Journal: Radiother Oncol Date: 2003-03 Impact factor: 6.280
Authors: Graham W Warren; James R Marshall; K Michael Cummings; Benjamin A Toll; Ellen R Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; James L Mulshine; Nasser Hanna; Carolyn A Dresler Journal: J Oncol Pract Date: 2013-07-29 Impact factor: 3.840
Authors: Jose P Zevallos; Michael J Mallen; Cho Y Lam; Maher Karam-Hage; Jan Blalock; David W Wetter; Adam S Garden; Erich M Sturgis; Paul M Cinciripini Journal: Cancer Date: 2009-10-01 Impact factor: 6.921
Authors: Lucian Zhao; Dominic H Moon; Vladimir Avkshtol; Caitlin H Siropaides; Stephanie Terauchi; Andrew T Day; Baran D Sumer; Randall Hughes; David J Sher Journal: Support Care Cancer Date: 2022-06-06 Impact factor: 3.359